In the ever-evolving world of the stock market, small-cap companies often hide some of the most exciting opportunities. These nimble businesses might not be household names yet, but they can deliver substantial returns for investors willing to look beyond the ASX 100. If you’re hunting for the best small cap ASX stocks, or scanning the market for undervalued ASX shares 2025, two companies deserve a serious look: AVITA Medical Inc (ASX: AVH) and Universal Store Holdings Ltd (ASX: UNI).

These businesses operate in very different sectors—biotech and fashion retail—but what they share is a clear growth path and the potential to become the next big ASX stock. Let’s take a closer look at why these two high growth small cap stocks are worth your attention.

AVITA Medical Inc (ASX: AVH) – Leading the Way in Regenerative Medicine

AVITA Medical is a U.S.-headquartered biotech firm listed on the ASX that focuses on regenerative skin treatments. Its flagship product, the RECELL System, is a game-changer in treating acute skin injuries, especially thermal burns. This system allows clinicians to use a small sample of a patient’s own skin to create a spray-on solution of skin cells that helps accelerate healing. It’s cutting-edge technology with real-world applications—and big commercial potential.

In FY2024, AVITA posted revenue of A$97.41 million, up 29% year-over-year, reflecting both growing product demand and expanding clinical adoption. A major catalyst came in December 2024, when the company received FDA approval for two new products: Cohealyx and RECELL GO® mini. These additions target the acute wound care market, one of the largest segments in global healthcare.

Why AVITA Could Be a Game-Changer

AVITA began by focusing on burn treatments, but its technology has broader applications. The company is now moving into other areas like vitiligo (a skin pigmentation disorder) and chronic wound healing. These new directions open the door to a significantly larger addressable market, increasing the company’s long-term value proposition.

Its growing U.S. presence is another major strength. The U.S. healthcare system represents one of the world’s most lucrative markets, and AVITA is steadily carving out a niche for itself. For investors seeking small cap investment Australia opportunities that offer exposure to the global biotech boom, AVITA is a compelling choice.

If you’re building a portfolio focused on ASX penny stocks to watch out for, AVITA’s innovative product line and consistent growth make it a standout candidate.

Universal Store Holdings Ltd (ASX: UNI) – Fashion Forward, Profits Up

If biotech isn’t your style, fashion retail might be—and Universal Store has proven it knows how to make trends pay. This Australian company caters primarily to the youth fashion market, offering a wide range of on-trend clothing, accessories, and footwear. With over 70 stores across the country and a growing online presence, UNI has become a go-to brand for younger Australian shoppers.

The company made headlines in 2022 with the acquisition of Thrills, a popular fashion brand aimed at youth culture. This strategic move diversified UNI’s product line and helped it appeal to a broader audience. In FY2024, the company reported revenue of A$288.5 million, a 9.68% increase from the previous year. Even more impressive was the net income of A$34.3 million, which marked a 45.6% increase year-on-year.

Why Universal Store Is Worth Watching

Universal Store has a few key strengths that position it well for future growth. First, it knows how to connect with its audience. By staying ahead of fashion trends and offering the right products at the right time, the company remains relevant in a competitive market. Second, its focus on omnichannel retailing—integrating online and offline experiences—gives it the flexibility to scale efficiently.

Lastly, the company offers dividends—a rare trait among small caps. In FY2024, UNI paid out A$0.19 per share, providing not only growth potential but also a stream of income. For investors seeking undervalued ASX shares 2025 with real earnings and shareholder returns, Universal Store fits the bill.

UNI is not just a fashion retailer—it’s a profitable, dividend-paying company with room to grow. For anyone scanning the market for high growth small cap stocks, UNI’s rising earnings and strong brand make it one of the ASX penny stocks to watch out for this year.

Final Thoughts: Don’t Overlook the Underdogs

While large-cap stocks get most of the media spotlight, small cap investment Australia offers a world of opportunities for those willing to dig deeper. AVITA Medical and Universal Store Holdings may be small in size, but their business models, financial growth, and forward momentum suggest they could be the next big ASX stock.

Both companies highlight the diversity of opportunities in the best small cap ASX stocks category. AVITA is pushing the boundaries of medical science with new products and expanding global reach. Universal Store is capturing the energy of Australia’s youth fashion scene with strong revenues and rising profits.

In 2025, when many investors are looking to reduce risk and seek quality growth, these two stocks offer a rare combination of innovation, market relevance, and financial performance. They aren’t just ASX penny stocks to watch out for—they’re potential future leaders hiding in plain sight.

So, if you’re building your list of high growth small cap stocks, don’t miss out on these two rising stars. Whether you’re into biotech breakthroughs or retail revolutions, AVH and UNI offer something special for the savvy, future-focused investor.

Disclaimer:

Pristine Gaze Pty Ltd trading as Pristine Gaze (ABN 66 680 815 678) and (ACN 680 815 678) is a Corporate Authorised Representative (CAR No. 001312049) of Alpha Securities Pty Ltd (AFSL 330757). The information provided is general information only. Any advice is general advice only. No consideration has been given or will be given to individual objectives, financial situation, or specific needs of any particular person or organisation. The decision to engage our services and the method selected is a personal decision and involves inherent risks, and you must undertake your own investigations and obtain independent advice regarding suitability for your circumstances. Past performance, examples, or projections are not indicative of future results. While we strive to provide accurate information, we make no guarantees regarding the accuracy or completeness of our materials. The website may also contain links to third-party websites or resources, for which Pristine Gaze is not responsible. All content and intellectual property on the Pristine Gaze website, including but not limited to text, graphics, logos, and images, are the property of Pristine Gaze and are protected by applicable copyright and trademark laws. By accessing or using the Pristine Gaze website, you acknowledge and agree to the terms of this disclaimer. Please read our Terms and Conditions, Privacy Policy and Financial Service Guide for further information. Please read our Terms and Conditions, Privacy Policy and Financial Service Guide for further information.